- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Gaithersburg Today
By the People, for the People
Remedy Plan Therapeutics Appoints New CFO and Business Officer
Jotin Marango, M.D., Ph.D., joins the leadership team of the clinical-stage biotech company.
Apr. 8, 2026 at 1:42pm
Got story updates? Submit your updates here. ›
Remedy Plan Therapeutics, a clinical-stage biopharmaceutical company, has appointed Jotin Marango, M.D., Ph.D., as its new Chief Financial and Business Officer. Marango brings extensive experience in the biotech industry, having previously held leadership roles at several other pharmaceutical companies.
Why it matters
This appointment is significant for Remedy Plan Therapeutics as it looks to advance its pipeline of drug candidates and navigate the complex financial and business landscape of the biotech industry. Marango's expertise will be crucial in guiding the company's strategic decisions and securing the necessary funding to support its R&D efforts.
The details
In his new role, Marango will be responsible for overseeing the company's financial operations, including fundraising, budgeting, and financial reporting. He will also play a key role in shaping Remedy Plan's business strategy and partnerships as the company works to bring its therapies to market.
- Jotin Marango was appointed as Remedy Plan Therapeutics' new Chief Financial and Business Officer on April 8, 2026.
The players
Remedy Plan Therapeutics
A clinical-stage biopharmaceutical company focused on developing innovative therapies for various medical conditions.
Jotin Marango, M.D., Ph.D.
An experienced biotech executive who has previously held leadership roles at several pharmaceutical companies.
The takeaway
Remedy Plan Therapeutics' appointment of Jotin Marango as its new Chief Financial and Business Officer signals the company's commitment to strengthening its leadership team and positioning itself for future growth and success in the highly competitive biotech industry.
